• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Abivax SA - American Depositary Shares (NQ: ABVX )

    7.120 -0.540 (-7.05%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 338,692
    Open 7.600
    Bid (Size) 6.800 (10)
    Ask (Size) 7.470 (1)
    Prev. Close 7.660
    Today's Range 6.650 - 7.600
    52wk Range 6.650 - 17.02
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Abivax Announces a Change to the Composition of its Board of Directors
    From Abivax
    Via GlobeNewswire
    This Veeva Systems Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
    Via Benzinga

    Performance

    YTD
    -34.07%
    -34.07%
    1 Month
    -16.82%
    -16.82%
    3 Month
    -38.62%
    -38.62%
    6 Month
    -46.14%
    -46.14%
    1 Year
    -34.07%
    -34.07%

    More News

    Read More
    Abivax Establishes an At-the-Market (ATM) Program on Nasdaq
    From Abivax
    Via GlobeNewswire
    Abivax presents third quarter 2024 key financial information
    From Abivax
    Via GlobeNewswire
    Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax
    From Abivax
    Via GlobeNewswire
    Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation
    From Abivax
    Via GlobeNewswire
    Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease
    From Abivax
    Via GlobeNewswire
    Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance
    From Abivax
    Via GlobeNewswire
    Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024
    From Abivax
    Via GlobeNewswire
    Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model
    From Abivax
    Via GlobeNewswire
    Abivax presents first-half 2024 financial results
    From Abivax
    Via GlobeNewswire
    Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone
    From Abivax
    Via GlobeNewswire
    Abivax Provides Operational and Key Program Update
    From Abivax
    Via GlobeNewswire
    AMC Networks, Louisiana-Pacific And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting
    From Abivax
    Via GlobeNewswire
    Earnings Scheduled For April 2, 2024
    Via Benzinga
    Abivax Announces Presentation of Four Abstracts for Obefazimod in Ulcerative Colitis and Sponsorship of Scientific Symposium at The 19th Congress of European Crohn’s and Colitis Organization (ECCO)
    Via ACCESSWIRE
    Cross-Border Logistics Provider Globavend Debuts In Quiet Week
    Via Talk Markets
    Webuy Shares Soar In Market Debut
    Via Talk Markets
    Topics Initial Public Offering
    Exposures Securities Market
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.